Current projects

UVEAL MELANOMA AND LIVER METASTASIS: STUDY OF FACTORS ASSOCIATED WITH METASTATIC DISSEMINATION AND PROGNOSTIC IMPLICATIONS

Health research project-ISCIII PI15/01461. Project duration: 2016-2018. Principal investigator: Josep Maria Caminal. Co-investigators: Daniel Lorenzo, Estefanía Cobos, Marcos Javier Rubio, Montserrat Gomà, Mar Varela, María José Paúles.

Learn more

UVEAL MELANOMA AND LIVER METASTASIS: PREDICTIVE USE OF MOLECULAR ALTERATIONS AND THERAPEUTIC OPPORTUNITIES

Health research project-ISCIII PI18/01131. Project duration: 2019-2021. Principal investigators: Josep Maria Caminal, Àngels Fabra. Co-investigators: Antonia Vinyals, Montserrat Gomà, Estefanía Cobos, Daniel Lorenzo, Eduard Cabré, María José Paúles, Mar Varela, Cristina Gutiérrez.

Current clinical trials

Update pending

Previous experience

Ophthalmic oncology TNM staging validation project.

Promoter: AJCC-UICC Eye Cancer Staging Validation Study Group. Project duration: 2012-2013. Principal investigator: Josep Maria Caminal.

Healthy aging of the eye to correct ocular diseases and visual impairment: an epigenetic approach.

Sponsor: RecerCaixa Foundation. Project duration: 2013-2015. Principal investigators: María Berdasco Menéndez. Co-investigators: Manel Esteller Badosa, Antonio Gómez Moruno, Miguel López Pato, Josep Maria Caminal Mitjana, Marcos J. Rubio Caso, Luis Arias Barquet, Jaume Català Mora.

Exploring epigenetic-targeting approaches as novel therapeutic avenues for metastasis progression in uveal melanoma.

Sponsor: Federación Española de Enfermedades Raras (FEDER), Federación Española de Enfermedades Neuromusculares (ASEM) y Fundación Isabel Gemio; call: “Todos somos raros, todos somos únicos”. Project duration: 2 years. Principal investigator: María Berdasco Menéndez. Co-investigators: Antonio Gómez Moruno, Miguel López Pato, Josep Maria Caminal Mitjana, Marcos J. Rubio Caso, Dr. Jaume Català Mora.